- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x YII: 3-[(3-aminophenyl)methyl]-5-methyl-7-[methyl(oxidanyl)-$l^{3}-sulfanyl]pyridazino[4,5-b]indol-4-one(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 7 residues within 4Å:- Chain A: R.62, G.65, N.89, H.483, I.488, F.489, P.490
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.89, A:H.483
- Water bridges: A:G.65, A:G.65, A:G.487
EDO.3: 11 residues within 4Å:- Chain A: N.337, V.371, L.372, D.373, G.374, I.408, L.413, R.464, R.486
- Ligands: YII.1, YII.18
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.337, A:V.371, A:R.486, A:R.486
EDO.5: 4 residues within 4Å:- Chain A: N.337, R.338, R.462, Y.463
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.337, A:Y.463
EDO.19: 7 residues within 4Å:- Chain B: R.62, G.65, N.89, H.483, I.488, F.489, P.490
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.89, B:H.483
- Water bridges: B:G.65, B:G.65, B:G.487
EDO.20: 11 residues within 4Å:- Chain B: N.337, V.371, L.372, D.373, G.374, I.408, L.413, R.464, R.486
- Ligands: YII.1, YII.18
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.337, B:V.371, B:R.486, B:R.486
EDO.22: 4 residues within 4Å:- Chain B: N.337, R.338, R.462, Y.463
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.337, B:Y.463
EDO.36: 7 residues within 4Å:- Chain C: R.62, G.65, N.89, H.483, I.488, F.489, P.490
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.89
- Water bridges: C:G.65, C:G.65, C:G.487
EDO.37: 11 residues within 4Å:- Chain C: N.337, V.371, L.372, D.373, G.374, I.408, L.413, R.464, R.486
- Ligands: YII.35, YII.52
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.337, C:V.371, C:R.486, C:R.486
EDO.39: 4 residues within 4Å:- Chain C: N.337, R.338, R.462, Y.463
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.337, C:Y.463
EDO.53: 7 residues within 4Å:- Chain D: R.62, G.65, N.89, H.483, I.488, F.489, P.490
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.89
- Water bridges: D:G.65, D:G.65, D:G.487
EDO.54: 11 residues within 4Å:- Chain D: N.337, V.371, L.372, D.373, G.374, I.408, L.413, R.464, R.486
- Ligands: YII.35, YII.52
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.337, D:V.371, D:R.486, D:R.486
EDO.56: 4 residues within 4Å:- Chain D: N.337, R.338, R.462, Y.463
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.337, D:Y.463
- 4 x OXL: OXALATE ION(Non-covalent)
OXL.4: 10 residues within 4Å:- Chain A: K.289, E.291, M.310, A.312, R.313, G.314, D.315, T.347
- Ligands: SO4.15, MG.16
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:G.314, A:D.315, A:D.315, A:T.347, A:T.347, A:T.347
- Water bridges: A:K.289, A:K.289
- Salt bridges: A:R.92, A:K.289, A:K.289
OXL.21: 10 residues within 4Å:- Chain B: K.289, E.291, M.310, A.312, R.313, G.314, D.315, T.347
- Ligands: SO4.32, MG.33
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:G.314, B:D.315, B:D.315, B:T.347, B:T.347, B:T.347
- Water bridges: B:K.289, B:K.289
- Salt bridges: B:R.92, B:K.289, B:K.289
OXL.38: 10 residues within 4Å:- Chain C: K.289, E.291, M.310, A.312, R.313, G.314, D.315, T.347
- Ligands: SO4.49, MG.50
9 PLIP interactions:9 interactions with chain C- Hydrogen bonds: C:G.314, C:D.315, C:T.347, C:T.347
- Water bridges: C:K.289, C:K.289
- Salt bridges: C:R.92, C:K.289, C:K.289
OXL.55: 10 residues within 4Å:- Chain D: K.289, E.291, M.310, A.312, R.313, G.314, D.315, T.347
- Ligands: SO4.66, MG.67
9 PLIP interactions:9 interactions with chain D- Hydrogen bonds: D:G.314, D:D.315, D:T.347, D:T.347
- Water bridges: D:K.289, D:K.289
- Salt bridges: D:R.92, D:K.289, D:K.289
- 40 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 8 residues within 4Å:- Chain A: T.451, K.452, S.453, G.454, R.455, S.456, S.538, G.539
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: H.97, R.139
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: R.395, H.398, R.402
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: K.85, R.125
- Ligands: SO4.10
Ligand excluded by PLIPSO4.10: 2 residues within 4Å:- Chain A: K.85
- Ligands: SO4.9
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain A: R.455, H.458, R.462
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain A: S.96, H.97, G.98
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain A: H.293, E.294, R.297
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain A: K.266, R.298
Ligand excluded by PLIPSO4.15: 6 residues within 4Å:- Chain A: R.92, N.94, D.132, K.289
- Ligands: OXL.4, MG.16
Ligand excluded by PLIPSO4.23: 8 residues within 4Å:- Chain B: T.451, K.452, S.453, G.454, R.455, S.456, S.538, G.539
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain B: H.97, R.139
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain B: R.395, H.398, R.402
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain B: K.85, R.125
- Ligands: SO4.27
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain B: K.85
- Ligands: SO4.26
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain B: R.455, H.458, R.462
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain B: S.96, H.97, G.98
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain B: H.293, E.294, R.297
Ligand excluded by PLIPSO4.31: 2 residues within 4Å:- Chain B: K.266, R.298
Ligand excluded by PLIPSO4.32: 6 residues within 4Å:- Chain B: R.92, N.94, D.132, K.289
- Ligands: OXL.21, MG.33
Ligand excluded by PLIPSO4.40: 8 residues within 4Å:- Chain C: T.451, K.452, S.453, G.454, R.455, S.456, S.538, G.539
Ligand excluded by PLIPSO4.41: 2 residues within 4Å:- Chain C: H.97, R.139
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain C: R.395, H.398, R.402
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain C: K.85, R.125
- Ligands: SO4.44
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain C: K.85
- Ligands: SO4.43
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain C: R.455, H.458, R.462
Ligand excluded by PLIPSO4.46: 3 residues within 4Å:- Chain C: S.96, H.97, G.98
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain C: H.293, E.294, R.297
Ligand excluded by PLIPSO4.48: 2 residues within 4Å:- Chain C: K.266, R.298
Ligand excluded by PLIPSO4.49: 6 residues within 4Å:- Chain C: R.92, N.94, D.132, K.289
- Ligands: OXL.38, MG.50
Ligand excluded by PLIPSO4.57: 8 residues within 4Å:- Chain D: T.451, K.452, S.453, G.454, R.455, S.456, S.538, G.539
Ligand excluded by PLIPSO4.58: 2 residues within 4Å:- Chain D: H.97, R.139
Ligand excluded by PLIPSO4.59: 3 residues within 4Å:- Chain D: R.395, H.398, R.402
Ligand excluded by PLIPSO4.60: 3 residues within 4Å:- Chain D: K.85, R.125
- Ligands: SO4.61
Ligand excluded by PLIPSO4.61: 2 residues within 4Å:- Chain D: K.85
- Ligands: SO4.60
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain D: R.455, H.458, R.462
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain D: S.96, H.97, G.98
Ligand excluded by PLIPSO4.64: 3 residues within 4Å:- Chain D: H.293, E.294, R.297
Ligand excluded by PLIPSO4.65: 2 residues within 4Å:- Chain D: K.266, R.298
Ligand excluded by PLIPSO4.66: 6 residues within 4Å:- Chain D: R.92, N.94, D.132, K.289
- Ligands: OXL.55, MG.67
Ligand excluded by PLIP- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.16: 4 residues within 4Å:- Chain A: E.291, D.315
- Ligands: OXL.4, SO4.15
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.291, A:D.315, H2O.1, H2O.6
MG.33: 4 residues within 4Å:- Chain B: E.291, D.315
- Ligands: OXL.21, SO4.32
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.291, B:D.315, H2O.21, H2O.26
MG.50: 4 residues within 4Å:- Chain C: E.291, D.315
- Ligands: OXL.38, SO4.49
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.291, C:D.315, H2O.42, H2O.47
MG.67: 4 residues within 4Å:- Chain D: E.291, D.315
- Ligands: OXL.55, SO4.66
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:E.291, D:D.315, H2O.62, H2O.67
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.17: 4 residues within 4Å:- Chain A: E.437, K.441
- Chain C: R.418, V.433
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:R.418
NA.34: 4 residues within 4Å:- Chain B: E.437, K.441
- Chain D: R.418, V.433
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.437
NA.51: 4 residues within 4Å:- Chain A: R.418, V.433
- Chain C: E.437, K.441
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:E.437, C:E.437
NA.68: 4 residues within 4Å:- Chain B: R.418, V.433
- Chain D: E.437, K.441
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain B- Hydrogen bonds: D:E.437, B:R.418
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wubben, T.J. et al., Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis. Pharmaceuticals (2023)
- Release Date
- 2023-05-17
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x YII: 3-[(3-aminophenyl)methyl]-5-methyl-7-[methyl(oxidanyl)-$l^{3}-sulfanyl]pyridazino[4,5-b]indol-4-one(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x OXL: OXALATE ION(Non-covalent)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wubben, T.J. et al., Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis. Pharmaceuticals (2023)
- Release Date
- 2023-05-17
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A